A 15-amino acid pentadecapeptide studied for tissue repair via nitric oxide and angiogenesis pathways.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 500 mcg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 5 units |
| 10 mg | 1 mL | 10 mg/mL | 5 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 500 mcg. At 10 mg/mL, that draws to 5 units on a U-100 insulin syringe.
Modulates the nitric oxide signaling cascade to promote VEGF expression, new blood vessel formation, and fibroblast collagen production. Tends to accumulate at injury sites.
BPC-157 is commonly taken morning and evening.
Add 0.5 mL of bacteriostatic water to a 5 mg BPC-157 vial for a 10 mg/mL solution.
A common BPC-157 starting dose is 500 mcg, which at 10 mg/mL draws to 5 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the BPC-157 vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.